From IL-2 to IL-37: The expanding spectrum of anti-inflammatory cytokines

Nature Immunology

Volumn 13, Issue 10, 2012, Pages 925-931

  Banchereau, Jacques ^a   Pascual, Virginia ^a   O'Garra, Anne ^b  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; COLLAGEN; CYTOKINE; HLA G ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 26; INTERLEUKIN 27; INTERLEUKIN 35; INTERLEUKIN 37; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

EFFECTOR CELL; FEEDBACK SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKINS; MICE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84866555886     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2406     Document Type: Review

References (132)

1. Honda, K. & Littman, D.R. The microbiome in infectious disease and infammation. Annu. Rev. Immunol. 30, 759-795 (2012).
2. Lee, Y.K. & Mazmanian, S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330, 1768-1773 (2010).
3. Chow, J., Tang, H. & Mazmanian, S.K. Pathobionts of the gastrointestinal microbiota and infammatory disease. Curr. Opin. Immunol. 23, 473-480 (2011).
4. Hill, D.A. et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic infammation. Nat. Med. 18, 538-546 (2012).
5. Maloy, K.J. & Powrie, F. Intestinal homeostasis and its breakdown in infammatory bowel disease. Nature 474, 298-306 (2011).
6. Morelli, A.E. & Thomson, A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610-621 (2007). (Pubitemid 47123548)
7. Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003). (Pubitemid 37174545)
8. Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7, 83-92 (2006). (Pubitemid 41823872)
9. Josefowicz, S.Z., Lu, L.F. & Rudensky, A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564 (2012).
10. + regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490-500 (2010).
11. + regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30, 733-758 (2012).
12. + T-regulatory cells: toward therapy for human diseases. Immunol. Rev. 223, 391-421 (2008). (Pubitemid 351986179)
13. Pot, C., Apetoh, L. & Kuchroo, V.K. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin. Immunol. 23, 202-208 (2011).
14. Roncarolo, M.G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006). (Pubitemid 44116698)
15. Cheng, M.H. & Anderson, M.S. Monogenic autoimmunity. Annu. Rev. Immunol. 30, 393-427 (2012).
16. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001). (Pubitemid 32044513)
17. Wildin, R.S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20 (2001). (Pubitemid 32044512)
18. + regulatory T cells in human thymus and periphery. Immunity 28, 870-880 (2008).
19. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936-940 (2007).
20. + regulatory T cells. Nat. Rev. Immunol. 11, 119-130 (2011).
21. + Treg cells that phenotypically mirror effector Th cells. Blood 119, 4430-4440 (2012).
22. + T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911 (2009).
23. Vignali, D.A., Collison, L.W. & Workman, C.J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532 (2008).
24. + T regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
25. + regulatory T cells under infammatory or non-infammatory conditions. Semin. Immunol. 23, 424-430 (2011).
26. Qureshi, O.S. et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603 (2011).
27. + regulatory T cells in systemic autoimmune diseases. Autoimmun. Rev. 10, 744-755 (2011).
28. Hippen, K.L., Riley, J.L., June, C.H. & Blazar, B.R. Clinical perspectives for regulatory T cells in transplantation tolerance. Semin. Immunol. 23, 462-468 (2011).
29. + regulatory T-cell activation and expansion. J. Allergy Clin. Immunol. 123, 749-755 (2009).
30. Steinman, L., Merrill, J.T., McInnes, I.B. & Peakman, M. Optimization of current and future therapy for autoimmune diseases. Nat. Med. 18, 59-65 (2012).
31. Malek, T.R. & Castro, I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33, 153-165 (2010).
32. Schorle, H., Holtschke, T., Hunig, T., Schimpl, A. & Horak, I. Development and function of T cells in mice rendered interleukin-2 defcient by gene targeting. Nature 352, 621-624 (1991). (Pubitemid 21912393)
33. Kündig, T.M. et al. Immune responses in interleukin-2-defcient mice. Science 262, 1059-1061 (1993).
34. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 186, 3808-3821 (2011).
35. Caudy, A.A., Reddy, S.T., Chatila, T., Atkinson, J.P. & Verbsky, J.W. CD25 defciency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119, 482-487 (2007).
36. Pociot, F. et al. Genetics of type 1 diabetes: what's next? Diabetes 59, 1561-1571 (2010).
37. Hulme, M.A., Wasserfall, C.H., Atkinson, M.A. & Brusko, T.M. Central role for interleukin-2 in type 1 diabetes. Diabetes 61, 14-22 (2012).
38. Tang, Q. et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687-697 (2008).
39. Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39, 329-337 (2007). (Pubitemid 46328484)
40. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735 (2005). (Pubitemid 40395118)
41. Rabinovitch, A., Suarez-Pinzon, W.L., Shapiro, A.M., Rajotte, R.V. & Power, R. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes 51, 638-645 (2002). (Pubitemid 34760170)
42. Grinberg-Bleyer, Y. et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207, 1871-1878 (2010).
43. Liston, A., Siggs, O.M. & Goodnow, C.C. Tracing the action of IL-2 in tolerance to islet-specifc antigen. Immunol. Cell Biol. 85, 338-342 (2007). (Pubitemid 46878927)
44. Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007). (Pubitemid 46413906)
45. Yang, X.P. et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247-254 (2011).
46. H17 differentiation by directly silencing Il2 expression. Nat. Immunol. 13, 770-777 (2012).
47. + regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34, 409-421 (2011).
48. + regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34, 422-434 (2011).
49. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663 (2011).
50. Deenick, E.K., Ma, C.S., Brink, R. & Tangye, S.G. Regulation of T follicular helper cell formation and function by antigen presenting cells. Curr. Opin. Immunol. 23, 111-118 (2011).
51. Vinuesa, C.G. & Cyster, J.G. How T cells earn the follicular rite of passage. Immunity 35, 671-680 (2011).
52. Morita, R. et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specifc subsets that differentially support antibody secretion. Immunity 34, 108-121 (2011).
53. Ballesteros-Tato, A. et al. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 36, 847-856 (2012).
54. Johnston, R.J., Choi, Y.S., Diamond, J.A., Yang, J.A. & Crotty, S. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209, 243-250 (2012).
55. Malek, T.R. & Khan, W.N. IL-2: Fine-tuning the Germinal Center Reaction. Immunity 36, 702-704 (2012).
56. + regulatory T cells in cancer patients. Blood 107, 2409-2414 (2006). (Pubitemid 43345561)
57. Koreth, J. et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365, 2055-2066 (2011).
58. Saadoun, D. et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 365, 2067-2077 (2011).
59. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001). (Pubitemid 32368050)
60. O'Garra, A., Barrat, F.J., Castro, A.G., Vicari, A. & Hawrylowicz, C. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 223, 114-131 (2008). (Pubitemid 351986180)
61. Sabat, R. et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 21, 331-344 (2010).
62. Commins, S., Steinke, J.W. & Borish, L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J. Allergy Clin. Immunol. 121, 1108-1111 (2008).
63. Li, M.O. & Flavell, R.A. Contextual regulation of infammation: a duet by transforming growth factor-ß and interleukin-10. Immunity 28, 468-476 (2008). (Pubitemid 351467045)
64. Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010).
65. Murray, P.J. & Smale, S.T. Restraint of infammatory signaling by interdependent strata of negative regulatory pathways. Nat. Immunol. 13, 916-924 (2012).
66. Izcue, A., Coombes, J.L. & Powrie, F. Regulatory lymphocytes and intestinal infammation. Annu. Rev. Immunol. 27, 313-338 (2009).
67. Kühn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-defcient mice develop chronic enterocolitis. Cell 75, 263-274 (1993). (Pubitemid 23320290)
68. Glocker, E.O., Kotlarz, D., Klein, C, Shah, N. & Grimbacher, B. IL-10 and IL-10 receptor defects in humans. Ann. NY Acad. Sci. 1246, 102-107 (2011).
69. Glocker, E.O. et al. Infammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009).
70. Gregori, S. et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116, 935-944 (2011).
71. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J. Exp. Med. 195, 603-616 (2002). (Pubitemid 34461505)
72. + regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34, 554-565 (2011).
73. Chaudhry, A. et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated infammation. Immunity 34, 566-578 (2011).
74. Murai, M. et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178-1184 (2009).
75. Rubtsov, Y.P. et al. Regulatory T cell-derived interleukin-10 limits infammation at environmental interfaces. Immunity 28, 546-558 (2008).
76. Rousset, F. et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89, 1890-1893 (1992).
77. Defrance, T. et al. Interleukin 10 and transforming growth factor ß cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175, 671-682 (1992).
78. Li, D. et al. Targeting self-and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J. Exp. Med. 209, 109-121 (2012).
79. Li, M.O. & Flavell, R.A. TGF-ß: a master of all T cell trades. Cell 134, 392-404 (2008).
80. Tran, D.Q. TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells. J. Mol. Cell Biol. 4, 29-37 (2012).
81. Konkel, J.E. & Chen, W. Balancing acts: the role of TGF-β in the mucosal immune system. Trends Mol. Med. 17, 668-676 (2011).
82. Regateiro, F.S., Howie, D., Cobbold, S.P. & Waldmann, H. TGF-β in transplantation tolerance. Curr. Opin. Immunol. 23, 660-669 (2011).
83. Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal infammatory disease. Nature 359, 693-699 (1992).
84. Li, X. et al. IL-35 is a novel responsive anti-infammatory cytokine-a new system of categorizing anti-infammatory cytokines. PLoS ONE 7, e33628 (2012).
85. Chen, W. et al. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003). (Pubitemid 38032120)
86. + T cells and, together with TGF-β, generates IL-9+IL-10+Foxp3-effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
87. Sun, CM. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).
88. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007). (Pubitemid 47236314)
89. + regulatory T cells. Nat. Immunol. 9, 632-640 (2008). (Pubitemid 351712634)
90. H17 cells in the absence of TGF-beta signalling. Nature 467, 967-971 (2010).
91. Gutcher, I. et al. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. Immunity 34, 396-408 (2011).
92. Li, M.O., Wan, Y.Y. & Flavell, R.A. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 26, 579-591 (2007). (Pubitemid 46756347)
93. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517 (2009).
94. Cerutti, A. & Rescigno, M. The biology of intestinal immunoglobulin A responses. Immunity 28, 740-750 (2008). (Pubitemid 351784512)
95. Litinskiy, M.B. et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829 (2002).
96. Dullaers, M. et al. A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity 30, 120-129 (2009).
97. Shi, M. et al. Latent TGF-β structure and activation. Nature 474, 343-349 (2011).
98. Tran, D.Q. et al. GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 106, 13445-13450 (2009).
99. 8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365 (2007). (Pubitemid 47443473)
100. Grainger, J.R. et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J. Exp. Med. 207, 2331-2341 (2010).
101. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
102. Li, M.O., Sanjabi, S. & Flavell, R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25, 455-471 (2006). (Pubitemid 44354214)
103. Marie, J.C., Liggitt, D. & Rudensky, A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specifc targeting of transforming growth factor-beta receptor. Immunity 25, 441-454 (2006). (Pubitemid 44354215)
104. Vignali, D.A. & Kuchroo, V.K. IL-12 family cytokines: immunological playmakers. Nat. Immunol. 13, 722-728 (2012).
105. Molle, C, Goldman, M. & Goriely, S. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J. Immunol. 184, 1784-1792 (2010).
106. + T cells. Immunity 16, 779-790 (2002).
107. Villarino, A. et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19, 645-655 (2003). (Pubitemid 37490790)
108. Hamano, S. et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinfammatory cytokine production. Immunity 19, 657-667 (2003). (Pubitemid 37490791)
109. Pot, C., Apetoh, L. & Kuchroo, V.K. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin. Immunol. 23, 202-208 (2011).
110. Wojno, E.D. & Hunter, C.A. New directions in the basic and translational biology of interleukin-27. Trends Immunol. 33, 91-97 (2012).
111. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861 (2010).
112. Ansari, N.A. et al. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J. Immunol. 186, 3977-3985 (2011).
113. Wojno, E.D. et al. A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 187, 266-273 (2011).
114. Cox, J.H. et al. IL-27 promotes T cell-dependent colitis through multiple mechanisms. J. Exp. Med. 208, 115-123 (2011).
115. Stumhofer, J.S. et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 11, 1119-1126 (2010).
116. Dibra, D. et al. Interleukin-30: a novel antiinfammatory cytokine candidate for prevention and treatment of infammatory cytokine-induced liver injury. Hepatology 55, 1204-1214 (2012).
117. Collison, L.W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007). (Pubitemid 350190247)
118. Chaturvedi, V., Collison, L.W., Guy, C.S., Workman, C.J. & Vignali, D.A. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J. Immunol. 186, 6661-6666 (2011).
119. Collison, L.W. et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101 (2010).
120. Bettini, M., Castellaw, A.H., Lennon, G.P., Burton, A.R. & Vignali, D.A. Prevention of autoimmune diabetes by ectopic pancreatic beta-cell expression of interleukin-35. Diabetes 61, 1519-1526 (2012).
121. + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 184, 7144-7153 (2010).
122. Seyerl, M. et al. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur. J. Immunol. 40, 321-329 (2010).
123. Dunn, E., Sims, J.E., Nicklin, M.J. & O'Neill, L.A. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol. 22, 533-536 (2001). (Pubitemid 33016389)
124. Kumar, S. et al. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-γ production. Cytokine 18, 61-71 (2002). (Pubitemid 34754095)
125. Nold, M.F. et al. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11, 1014-1022 (2010).
126. McNamee, E.N. et al. Interleukin 37 expression protects mice from colitis. Proc. Natl. Acad. Sci. USA 108, 16711-16716 (2011).
127. Bulau, A.M. et al. In vivo expression of interleukin-37 reduces local and systemic infammation in concanavalin A-induced hepatitis. ScientifcWorldJournal 11, 2480-2490 (2011).
128. Sakaguchi, S., Powrie, F. & Ransohoff, R.M. Re-establishing immunological self-tolerance in autoimmune disease. Nat. Med. 18, 54-58 (2012).
129. Schwager, K. et al. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Hum. Reprod. 26, 2344-2352 (2011).
130. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779 (2001). (Pubitemid 32983013)
131. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204, 191-201 (2007). (Pubitemid 46148769)
132. + T cells in NOD mice. Proc. Natl. Acad. Sci. USA 105, 6374-6379 (2008). (Pubitemid 351758353)